Harbin Pharmaceutical Group No.6 Pharmaceutical Factory, founded in 1977, is a comprehensive enterprise that mainly produces chemicals, supplemented by health food and beverages.
1993 After the establishment of Harbin Pharmaceutical Group Co., Ltd., Harbin Pharmaceutical No.6 Factory was one of the branches of Harbin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Harbin Pharmaceutical Group") is a Sino-foreign joint venture. State-owned shares account for 45%, CITIC Capital Iceland Investment Co., Ltd. and Huaping Iceland Investment Co., Ltd. each hold 22.5%, and Harbin State-owned Enterprise Restructuring Management Consulting Co., Ltd. holds 10%. Harbin SASAC is the largest shareholder. It owns Harbin Pharmaceutical Co., Ltd. and Renmin Tongtai, two listed companies.
Extended data management team: Zhang Lijun, former director of Harbin North Pharmaceutical Factory, director and deputy general manager of Harbin Pharmaceutical Group Co., Ltd., chairman and general manager of Harbin Pharmaceutical Group Pharmaceutical Co., Ltd., and now chairman and general manager of Harbin Pharmaceutical Group Co., Ltd. ..
Business scope: tablets, hard capsules, granules, oral liquid (including Chinese medicine extract), syrup, oral liquid, rubber paste and gel paste (including Chinese medicine extract) (the drug production license is valid until June 65438+February 3, 20201); Production of packaging materials, production and sales of daily chemicals and medical devices; Food production.
Baidu Baike-Harbin Pharmaceutical No.6 Factory